The National Stock Exchange erupted into a frenzy of big-money maneuvers yesterday, December 3, as bulk deals surged past ₹5,000 crore in value, spotlighting a seismic shift in infrastructure holdings and relentless pharma action. With the Nifty 50 closing flat amid mixed global signals from U.S. Fed hints and domestic GST tweaks, these oversized trades—often a telltale of institutional repositioning—could foreshadow sector rotations into 2026. For retail investors tracking NSE bulk deals today, the action in NHIT and SPARC underscores how whales are betting big on yield stability and drug innovation pipelines, potentially juicing midcap rallies.
At the epicenter: National Highways Infra Trust (NHIT), where Singapore-based Nitro Asia Holdings scooped up a whopping 19.56 crore units in a ₹2,905 crore bulk buy at ₹148.53 per unit. This blockbuster move, per NSE data, effectively absorbed stakes offloaded by Canadian giants CPP Investment Board and 2452991 Ontario Ltd—each dumping 9.78 crore units for ₹1,452 crore apiece at the same price. Analysts whisper of a cross-border pivot toward Asia's infra boom, as NHIT's steady 9-10% yields lure yield-hungry funds amid bond market jitters.
Pharma heavyweights stole the show too, with Sun Pharma Advanced Research (SPARC) clocking net buys amid a trading tornado valued at over ₹800 crore. Fresh off a November pipeline milestone announcement, SPARC's frenzy hints at optimism around its specialty drug bets. Meanwhile, Hikal Ltd saw mirror-image bulk flips totaling ₹1,000 crore+, coinciding with promoter group amalgamation news that propelled its shares up 9% to ₹244.
Here's a snapshot of the top 15 NSE bulk deals by trade value (December 3, 2025), highlighting the high-rollers reshaping portfolios:
| Rank | Symbol | Security Name | Buy/Sell | Quantity (Lakhs) | Avg. Price (₹) | Value (₹ Cr) | Key Client |
|---|---|---|---|---|---|---|---|
| 1 | NHIT | National Highways Infra Trust | BUY | 19,560 | 148.53 | 2,905 | Nitro Asia Holdings II Pte Ltd |
| 2 | NHIT | National Highways Infra Trust | SELL | 9,780 | 148.53 | 1,453 | CPP Investment Board Pvt Holdings |
| 3 | NHIT | National Highways Infra Trust | SELL | 9,780 | 148.53 | 1,453 | 2452991 Ontario Ltd |
| 4 | CRAFTSMAN | Craftsman Automation Ltd | BUY | 14.49 | 6,935 | 1,005 | PI Opportunities AIF V LLP |
| 5 | CRAFTSMAN | Craftsman Automation Ltd | SELL | 14.49 | 6,935 | 1,005 | Pioneer Investment Fund |
| 6 | SPARC | Sun Pharma Advanced Research | SELL | 464.68 | 170.10 | 790 | NK Securities Research Pvt Ltd |
| 7 | SPARC | Sun Pharma Advanced Research | BUY | 464.68 | 170.01 | 790 | NK Securities Research Pvt Ltd |
| 8 | SPARC | Sun Pharma Advanced Research | SELL | 396.27 | 167.54 | 664 | Alphagrep Securities Pvt Ltd |
| 9 | SPARC | Sun Pharma Advanced Research | BUY | 396.27 | 167.44 | 664 | Alphagrep Securities Pvt Ltd |
| 10 | HIKAL | Hikal Limited | SELL | 213.04 | 246.29 | 525 | Musigma Securities |
| 11 | HIKAL | Hikal Limited | BUY | 213.04 | 246.15 | 524 | Musigma Securities |
| 12 | SPARC | Sun Pharma Advanced Research | BUY | 296.82 | 168.80 | 501 | Irage Broking Services LLP |
| 13 | SPARC | Sun Pharma Advanced Research | SELL | 288.04 | 167.18 | 482 | Musigma Securities |
| 14 | SPARC | Sun Pharma Advanced Research | BUY | 288.04 | 167.07 | 482 | Musigma Securities |
| 15 | HIKAL | Hikal Limited | SELL | 187.02 | 246.76 | 462 | NK Securities Research Pvt Ltd |
(Values rounded; excludes minor discrepancies from weighted averages. Source: NSE bulk deals disclosure.)
Deal Highlights & Market Whispers:
- NHIT's Stake Symphony: The ₹2,905 crore buy offsets exact sell volumes, netting zero change but signaling Asian funds' infra appetite. "This flip from Canadian to Singapore capital reflects yield chasing in toll roads," notes Emkay Global strategist Radhika Gupta, amid NHIT's 52-week high flirtation at ₹149.75 (up 1.5% yesterday).
- SPARC's Net Bull Run: Over ₹4,000 crore in two-way traffic, but buyers edged out sellers by ₹101 crore—fueled by post-Q2 pipeline buzz on dermatology assets. Volume spiked 28x average, pushing shares to ₹161 (up 20% YTD).
- HIKAL's Restructure Rally: ₹1,000+ crore in balanced buys/sells, timed with promoter mergers greenlit by MCA. Stock leaped 9.2% despite Q2 net loss of ₹35 crore, as analysts eye cost synergies in animal health verticals.
- Banking Bet: Karnataka Bank (KTKBANK) saw a ₹43 crore net buy by Aditya Kumar Halwasiya (21 lakh shares at ₹205.60), bucking sector caution on NPAs.
- Penny Plays Heat Up: Low-price runners like Davangere Sugar (₹32 crore net buy) and Ganga Forging (high-volume churn) drew arbitrage crowds, with deals under ₹3/share but quantities north of 1 crore units.
Investor Radar: Opportunities Amid the Storm? As bulk deal trackers dissect these moves, savvy players might view NHIT's stability and SPARC's innovation edge as 2026 anchors—especially with IPO GMP whispers heating up midcaps. Yet, caution reigns: Bulk flips like Craftsman's exact buy-sell mirror (₹1,005 crore each) scream short-term positioning, not conviction. "Track net flows over noise; volatility from FII outflows could amplify swings," warns Motilal Oswal's Siddhartha Khemka. Diversify via ETFs if dipping toes, and monitor 52-week highs for exit cues.
